Outcomes of HIV-positive patients with cryptococcal meningitis in the Americas

- This is a description of clinical outcomes of cryptococcal meningitis (CM) in persons with HIV-infection in a large Latin-American cohort.
- Mortality in HIV-infected patients with cryptococcal meningitis varies across sites, and is overall very high (42%).
- Many people in the cohort developed cryptococcal meningitis months to years after ART start (median time 743 days), suggesting possible ART failure or noncompliance.

BackgroundCryptococcal meningitis (CM) is associated with substantial mortality in HIV-infected patients. Optimal timing of antiretroviral therapy (ART) in persons with CM represents a clinical challenge, and the burden of CM in Latin America has not been well described. Studies suggest that early ART initiation is associated with higher mortality, but data from the Americas are scarce.MethodsHIV-infected adults in care between 1985-2014 at participating sites in the Latin America (the Caribbean, Central and South America network (CCASAnet)) and the Vanderbilt Comprehensive Care Clinic (VCCC) and who had CM were included. Survival probabilities were estimated. Risk of death when initiating ART within the first 2 weeks after CM diagnosis versus initiating between 2-8 weeks was assessed using dynamic marginal structural models adjusting for site, age, sex, year of CM, CD4 count, and route of HIV transmission.Findings340 patients were included (Argentina 58, Brazil 138, Chile 28, Honduras 27, Mexico 34, VCCC 55) and 142 (42%) died during the observation period. Among 151 patients with CM prior to ART 56 (37%) patients died compared to 86 (45%) of 189 with CM after ART initiation (p = 0.14). Patients diagnosed with CM after ART had a higher risk of death (p = 0.03, log-rank test). The probability of survival was not statistically different between patients who started ART within 2 weeks of CM (7/24, 29%) vs. those initiating between 2-8 weeks (14/53, 26%) (p = 0.96), potentially due to lack of power.InterpretationIn this large Latin-American cohort, patients with CM had very high mortality rates, especially those diagnosed after ART initiation. This study reflects the overwhelming burden of CM in HIV-infected patients in Latin America.